Welcome to our dedicated page for PCPC news (Ticker: PCPC), a resource for investors and traders seeking the latest updates and insights on PCPC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PCPC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PCPC's position in the market.
Periphas Capital Partnering Corporation (NYSE: PCPC) announced the expected redemption of its Class A common stock shares on December 28, 2022. The redemption price is estimated to be about
On November 29, 2022, Periphas Capital Partnering Corporation (PCPC) announced the redemption of all its outstanding Class A common stock shares, effective around December 21, 2022. Trading for these shares will end on December 14, 2022, with shares suspended from trading on December 15, 2022. The redemption amount per share will be disclosed later. Holders of Class B and Class F shares will not have redemption rights.
The company plans to file a Form 25 to delist its securities from the New York Stock Exchange.
Periphas Capital Partnering Corporation (NYSE: PCPC) announced its board has decided not to extend its corporate existence and will redeem all outstanding Class A common stock effective December 15, 2022. This decision follows the inability to negotiate a partnering transaction, leading to the cancellation of a special stockholder meeting originally scheduled for December 12, 2022. As a result, trading of Class A Shares will conclude on December 14, 2022. The company plans to file for delisting with the SEC and will redeem shares based on trust account funds.
Periphas Capital Partnering Corporation has announced the pricing of its initial public offering (IPO) of 14,400,000 CAPS™ at $25.00 each, expected to start trading on the NYSE under symbol PCPC.U on December 10, 2020. Each CAPS™ includes one share of Class A common stock and one-quarter warrant to purchase additional shares at $28.75. The offering is projected to close on December 14, 2020, with Evercore Group serving as the book-running manager. The company has granted a 45-day option to purchase an additional 2,160,000 CAPS™ to cover over-allotments.
FAQ
What is the market cap of PCPC (PCPC)?
